TAMOXIFEN RESPONSE IN PRE-AND POSTMENOPAUSAL BREAST CANCER PATIENTS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

11620275

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to the use of an inhibitor of the VEGFR2 receptor in the preparation of a pharmaceutical preparation for improving tamoxifen treatment response in pre- and postmenopausal breast cancer patients being estrogen receptor positive.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
FORSKARPATENT I SYD ABLUND

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Landberg, Goran Limhamn, SE 4 9
Ryden, Lisa Angelholm, SE 2 10

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation